About
Site Map
Contact Us
Search
A service of the
U.S. National Library of Medicine®
Home
Conditions
Genes
Chromosomes
Handbook
Glossary
Resources
Genes
>
NF2
>
References
These sources were used to develop the Genetics Home Reference
gene summary
on the
NF2
gene.
Ahronowitz I, Xin W, Kiely R, Sims K, MacCollin M, Nunes FP. Mutational spectrum of the NF2 gene: a meta-analysis of 12 years of research and diagnostic laboratory findings. Hum Mutat. 2007 Jan;28(1):1-12.
PubMed citation
Baser ME, Friedman JM, Evans DG. Increasing the specificity of diagnostic criteria for schwannomatosis. Neurology. 2006 Mar 14;66(5):730-2.
PubMed citation
Baser ME, Kuramoto L, Joe H, Friedman JM, Wallace AJ, Gillespie JE, Ramsden RT, Evans DG. Genotype-phenotype correlations for nervous system tumors in neurofibromatosis 2: a population-based study. Am J Hum Genet. 2004 Aug;75(2):231-9. Epub 2004 Jun 9.
PubMed citation
Baser ME; Contributors to the International NF2 Mutation Database. The distribution of constitutional and somatic mutations in the neurofibromatosis 2 gene. Hum Mutat. 2006 Apr;27(4):297-306. Review.
PubMed citation
Buckley PG, Mantripragada KK, Díaz de Ståhl T, Piotrowski A, Hansson CM, Kiss H, Vetrie D, Ernberg IT, Nordenskjöld M, Bolund L, Sainio M, Rouleau GA, Niimura M, Wallace AJ, Evans DG, Grigelionis G, Menzel U, Dumanski JP. Identification of genetic aberrations on chromosome 22 outside the NF2 locus in schwannomatosis and neurofibromatosis type 2. Hum Mutat. 2005 Dec;26(6):540-9.
PubMed citation
Entrez
Gene
Gutmann DH. The neurofibromatoses: when less is more. Hum Mol Genet. 2001 Apr;10(7):747-55. Review.
PubMed citation
Hanemann CO, Evans DG. News on the genetics, epidemiology, medical care and translational research of Schwannomas. J Neurol. 2006 Dec;253(12):1533-41. Review.
PubMed citation
Hirokawa Y, Tikoo A, Huynh J, Utermark T, Hanemann CO, Giovannini M, Xiao GH, Testa JR, Wood J, Maruta H. A clue to the therapy of neurofibromatosis type 2: NF2/merlin is a PAK1 inhibitor. Cancer J. 2004 Jan-Feb;10(1):20-6.
PubMed citation
Ikeda T, Hashimoto S, Fukushige S, Ohmori H, Horii A. Comparative genomic hybridization and mutation analyses of sporadic schwannomas. J Neurooncol. 2005 May;72(3):225-30.
PubMed citation
Lusis E, Gutmann DH. Meningioma: an update. Curr Opin Neurol. 2004 Dec;17(6):687-92. Review.
PubMed citation
MacCollin M, Willett C, Heinrich B, Jacoby LB, Acierno JS Jr, Perry A, Louis DN. Familial schwannomatosis: exclusion of the NF2 locus as the germline event. Neurology. 2003 Jun 24;60(12):1968-74.
PubMed citation
Musti M, Kettunen E, Dragonieri S, Lindholm P, Cavone D, Serio G, Knuutila S. Cytogenetic and molecular genetic changes in malignant mesothelioma. Cancer Genet Cytogenet. 2006 Oct 1;170(1):9-15. Review.
PubMed citation
Ramesh V. Merlin and the ERM proteins in Schwann cells, neurons and growth cones. Nat Rev Neurosci. 2004 Jun;5(6):462-70. Review.
PubMed citation
Reed N, Gutmann DH. Tumorigenesis in neurofibromatosis: new insights and potential therapies. Trends Mol Med. 2001 Apr;7(4):157-62. Review.
PubMed citation
Ruttledge MH, Rouleau GA. Role of the neurofibromatosis type 2 gene in the development of tumors of the nervous system. Neurosurg Focus. 2005 Nov 15;19(5):E6. Review.
PubMed citation
Uppal S, Coatesworth AP. Neurofibromatosis type 2. Int J Clin Pract. 2003 Oct;57(8):698-703. Review.
PubMed citation
Xiao GH, Chernoff J, Testa JR. NF2: the wizardry of merlin. Genes Chromosomes Cancer. 2003 Dec;38(4):389-99. Review.
PubMed citation
Yohay KH. The genetic and molecular pathogenesis of NF1 and NF2. Semin Pediatr Neurol. 2006 Mar;13(1):21-6. Review.
PubMed citation
Reviewed: March 2007
Published: May 20, 2013
Indicates a page outside Genetics Home Reference.